Last reviewed · How we verify
NCT03675997: GRAFTY
GRAFted Patients' anxieTY Report
trial testing HAD (Hospital Anxiety and Depression) scale in Autologous Transplant Indication in 30 participants. Completed in 20 October 2019.
10 September 2019
Quick facts
| Lead sponsor | Institut de Cancérologie de la Loire |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 7 November 2018 |
| Primary completion | 10 September 2019 |
| Estimated completion | 20 October 2019 |
| Sites | 1 location across France |
Drugs / interventions tested
- HAD (Hospital Anxiety and Depression) scale
Conditions studied
- Autologous Transplant Indication — all drugs for Autologous Transplant Indication →
Sponsor
Institut de Cancérologie de la Loire — full company profile →
Who can join
18 and older, any sex, with Autologous Transplant Indication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Autograft is a technique requiring several weeks of hospitalization in a protected environment and can be a source of anxiety of different natures for patients. In this study, level of anxiety will be reported weekly throughout hospitalizations for autologous transplant, to detect the most stressful period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03675997
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Institut de Cancérologie de la Loire trials
Trials by the same sponsor.
- NCT03840213 — Nutrition and Chemotherapy · unknown
- NCT03759626 — I2S-Health Prevention · NA · unknown
- NCT03323424 — Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers · Phase 2 · withdrawn
- NCT03743961 — Geriatric Intervention Contribution on Quality of Life of Elderly Patients With Metastatic Neoplasia · terminated
- NCT03706937 — The Treatment of Addictions in the Course of Care in Oncology: an Inventory of Fixtures Among Paramedical Professionals · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03675997 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institut de Cancérologie de la Loire
- Last refreshed: 29 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03675997.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing